human enteric neuron progenitor cell therapy (Takeda Pharmaceutical/Kyoto University)

N/A

Report date: 2025/01/26 19:32:50

Base Information

Drug Namehuman enteric neuron progenitor cell therapy (Takeda Pharmaceutical/Kyoto University)
Drug Alias Namehuman enteric neural progenitors derived from iPSCs (Takeda Pharmaceutical/Kyoto University)iPSC-derived enteric neuron progenitors (Takeda Pharmaceutical/Kyoto University)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Neural stem cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCongenital autonomic control failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKyoto University
China Registration ClassN/A

Develop Information

Active CompaniesKyoto UniversityTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCongenital autonomic control failure
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A